MARKET

TOI

TOI

The Oncology Institute Inc
NASDAQ
1.170
+0.010
+0.86%
Pre Market: 1.170 0 0.00% 08:00 04/18 EDT
OPEN
1.170
PREV CLOSE
1.160
HIGH
1.260
LOW
1.140
VOLUME
1
TURNOVER
0
52 WEEK HIGH
2.655
52 WEEK LOW
0.3300
MARKET CAP
86.95M
P/E (TTM)
-1.2712
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TOI last week (0408-0412)?
Weekly Report · 3d ago
Press Release: Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute Executive Brings Wealth of Experience in Advancing Value-Based Specialty Care Models. The oncology institute, Inc. And its affiliates announced the appointment of Jordan Mc inerney as the new chief development officer effective April 1, 2024. Mc innerney most recently served as the Chief Operations Officer of HOPCo.
Dow Jones · 04/08 12:00
Weekly Report: what happened at TOI last week (0401-0405)?
Weekly Report · 04/08 09:53
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
The Oncology Institute, Inc. And Healthly will offer cancer care services to patients in Southern California starting July 1, 2024. Healthly is a rapidly growing healthcare company with over 180 primary care physicians. The partnership aims to deliver comprehensive cancer care to patients across the region.
Barchart · 04/04 07:00
Oncology Institute Unveils Clear Financial Outlook for 2024
TipRanks · 04/03 20:12
Weekly Report: what happened at TOI last week (0325-0329)?
Weekly Report · 04/01 09:53
Oncology Institute’s Balancing Act: Navigating Goodwill Impairment Amid Financial Strains
TipRanks · 03/29 06:02
Oncology Institute Inc reports results for the quarter ended in December - Earnings Summary
Oncology Institute Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 21 cents per share. Revenue rose 20.1% to $85.79 million from a year ago. The average analyst rating on the shares is "strong buy"
Reuters · 03/28 16:33
More
About TOI
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Webull offers Oncology Institute Inc stock information, including NASDAQ: TOI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TOI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TOI stock methods without spending real money on the virtual paper trading platform.